{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"semax-chemo","title":"Semax for Chemo-Related Cognitive and Nerve Issues: Evidence Breakdown","body":"## What's breaking down\n\nChemotherapy often triggers two main layers of degeneration. One is chemo brain — trouble with memory, focus, and mental processing that can last months or years after treatment. The other is chemotherapy-induced peripheral neuropathy, with burning, numbness, or pain in hands and feet.\n\nThese happen because chemo agents damage neurons directly, raise inflammation in brain areas tied to cognition, and disrupt repair signals like BDNF. The result is breakdown that outpaces natural repair in many patients. Gabapentin and pregabalin mainly quiet pain signals without fixing the underlying nerve damage. Peptides like Semax are discussed for potential support of neural repair pathways instead.\n\n## Why Semax might help you\n\n1. What keeps failing: Chemo can lower BDNF levels and create cognitive fatigue plus neural stress similar to other neurotoxic loads.\n2. What Semax is studied to do: Research shows it raises BDNF protein and mRNA in the rat hippocampus, supporting neuron connections and cognitive function without sedation.\n3. Therefore for you: If your chemo brain or cognitive layer is active, Semax is examined because it targets repair at the BDNF/neural level rather than masking symptoms.\n\n## Why Gabapentin / pregabalin matters for you\n\n1. Drug: Gabapentin / pregabalin.\n2. What it does: Masks neuropathic pain signals from chemo-induced nerve damage; does not repair nerves.\n3. Therefore for you: It suppresses a signal. This can reduce daily pain load and improve sleep or function short-term, but it trades off against repair by not addressing the root degeneration — helpful for symptom control while other approaches target recovery.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive repair layer. Gabapentin/pregabalin handles symptom suppression for neuropathy. They address different parts of the picture — one for potential rebuilding, one for load reduction — without overlap in mechanism.\n\n## What the evidence actually shows\n\nNo human trials test Semax specifically in chemotherapy patients. All direct data on Semax and BDNF come from rat studies. One study gave Semax to rats and measured a 1.4-fold rise in BDNF protein plus increased trkB activation in the hippocampus, linked to better avoidance learning. Another showed Semax boosted BDNF mRNA after brain ischemia in rats.\n\nChemo brain evidence is separate: human reports and imaging link cisplatin and other agents to cognitive changes via inflammation and mitochondrial shifts in brain cells. No Semax data connects to these models.\n\nFor gabapentinoids in CIPN, a 2024 meta-analysis of human trials found pregabalin did not significantly prevent average pain or improve quality of life versus placebo. Results in treatment settings were inconsistent across small studies. Overall evidence grade remains limited.\n\n## What scientists say\n\nResearchers note Semax modulates BDNF/trkB in preclinical models of cognitive function. Reviews on chemo brain emphasize the need for agents that support neurogenesis or reduce neuroinflammation, but no publications include Semax. CIPN guidelines list gabapentinoids as options with weak or conflicting support.\n\n## What people say on Reddit\n\nAnecdotal threads mention Semax in nootropic or post-chemo recovery contexts for focus, though specific chemo experiences are rare and unverified. Users often pair cognitive peptides with standard care but report variable subjective effects.\n\n## What people say on X\n\nPosts about Semax focus on general cognitive or recovery uses rather than chemo. Occasional mentions link peptides to chemo brain discussions without controlled data or consistent outcomes reported.\n\n## What we do not know\n\nHuman pharmacokinetics, dosing, or safety of Semax during or after chemotherapy remain unstudied. Long-term effects on cancer outcomes or interactions with chemo agents are unknown. No data exist on whether BDNF changes from Semax translate to measurable cognitive gains in chemo survivors.\n\n## Safety and limits\n\nSemax has a history of use in certain countries for neurological conditions, but regulatory status and purity vary. Gabapentinoids carry standard side-effect profiles including dizziness and sedation. Anyone considering these approaches should consult their oncology team. Evidence does not support replacing standard care.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/semax-chemo/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human trials test Semax in chemotherapy patients.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Sets baseline that all Semax-chemo links are indirect.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Semax increased BDNF protein 1.4-fold and trkB phosphorylation in rat hippocampus.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Core mechanistic finding for neural repair discussion.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"A 2024 meta-analysis found pregabalin did not significantly prevent CIPN pain or improve QoL vs placebo.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Grades the drug chain evidence directly.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Chemo brain involves memory and thinking changes reported during and after cancer treatment.","section":"What's breaking down","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Defines the cognitive degeneration layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://www.sciencedirect.com/science/article/abs/pii/S0006899306022955","title":"Semax regulates BDNF and trkB expression in the rat hippocampus","quote":"a single application of Semax (50 μg/kg body weight) results in a maximal 1.4-fold increase of BDNF protein levels","summary":"Rat study showing Semax effect on BDNF.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:14:53.456Z","link_status":"http_403","quote_status":"unverified","prev":"genesis","hash":"265efa4f20337f232deab8250a7b1bc00e9d63351e05b71df1d975d7a69d7d7a"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy","quote":"pregabalin did not significantly improve average pain ... or quality of life","summary":"Meta-analysis on gabapentinoids in CIPN.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:14:53.456Z","link_status":"ok","quote_status":"unverified","prev":"265efa4f20337f232deab8250a7b1bc00e9d63351e05b71df1d975d7a69d7d7a","hash":"aa8003576365864f2d121f10c946dd17398f84ceb443dde38e213594119e9a8a"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/diseases-conditions/chemo-brain/symptoms-causes/syc-20351060","title":"Chemo brain - Symptoms and causes","quote":"trouble with thinking and memory that can happen during and after cancer treatment","summary":"Clinical description of chemo brain.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:14:53.456Z","link_status":"http_403","quote_status":"unverified","prev":"aa8003576365864f2d121f10c946dd17398f84ceb443dde38e213594119e9a8a","hash":"ae164c4e39bfa06897c008a29e9a221e77c7209b211c98e3a809d0550af70e21"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:14:54.117Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Semax for Chemo-Related Cognitive and Nerve Issues: Evidence Breakdown","register":"source_ledger","body":"## What's breaking down\n\nChemotherapy often triggers two main layers of degeneration. One is chemo brain — trouble with memory, focus, and mental processing that can last months or years after treatment. The other is chemotherapy-induced peripheral neuropathy, with burning, numbness, or pain in hands and feet.\n\nThese happen because chemo agents damage neurons directly, raise inflammation in brain areas tied to cognition, and disrupt repair signals like BDNF. The result is breakdown that outpaces natural repair in many patients. Gabapentin and pregabalin mainly quiet pain signals without fixing the underlying nerve damage. Peptides like Semax are discussed for potential support of neural repair pathways instead.\n\n## Why Semax might help you\n\n1. What keeps failing: Chemo can lower BDNF levels and create cognitive fatigue plus neural stress similar to other neurotoxic loads.\n2. What Semax is studied to do: Research shows it raises BDNF protein and mRNA in the rat hippocampus, supporting neuron connections and cognitive function without sedation.\n3. Therefore for you: If your chemo brain or cognitive layer is active, Semax is examined because it targets repair at the BDNF/neural level rather than masking symptoms.\n\n## Why Gabapentin / pregabalin matters for you\n\n1. Drug: Gabapentin / pregabalin.\n2. What it does: Masks neuropathic pain signals from chemo-induced nerve damage; does not repair nerves.\n3. Therefore for you: It suppresses a signal. This can reduce daily pain load and improve sleep or function short-term, but it trades off against repair by not addressing the root degeneration — helpful for symptom control while other approaches target recovery.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive repair layer. Gabapentin/pregabalin handles symptom suppression for neuropathy. They address different parts of the picture — one for potential rebuilding, one for load reduction — without overlap in mechanism.\n\n## What the evidence actually shows\n\nNo human trials test Semax specifically in chemotherapy patients. All direct data on Semax and BDNF come from rat studies. One study gave Semax to rats and measured a 1.4-fold rise in BDNF protein plus increased trkB activation in the hippocampus, linked to better avoidance learning. Another showed Semax boosted BDNF mRNA after brain ischemia in rats.\n\nChemo brain evidence is separate: human reports and imaging link cisplatin and other agents to cognitive changes via inflammation and mitochondrial shifts in brain cells. No Semax data connects to these models.\n\nFor gabapentinoids in CIPN, a 2024 meta-analysis of human trials found pregabalin did not significantly prevent average pain or improve quality of life versus placebo. Results in treatment settings were inconsistent across small studies. Overall evidence grade remains limited.\n\n## What scientists say\n\nResearchers note Semax modulates BDNF/trkB in preclinical models of cognitive function. Reviews on chemo brain emphasize the need for agents that support neurogenesis or reduce neuroinflammation, but no publications include Semax. CIPN guidelines list gabapentinoids as options with weak or conflicting support.\n\n## What people say on Reddit\n\nAnecdotal threads mention Semax in nootropic or post-chemo recovery contexts for focus, though specific chemo experiences are rare and unverified. Users often pair cognitive peptides with standard care but report variable subjective effects.\n\n## What people say on X\n\nPosts about Semax focus on general cognitive or recovery uses rather than chemo. Occasional mentions link peptides to chemo brain discussions without controlled data or consistent outcomes reported.\n\n## What we do not know\n\nHuman pharmacokinetics, dosing, or safety of Semax during or after chemotherapy remain unstudied. Long-term effects on cancer outcomes or interactions with chemo agents are unknown. No data exist on whether BDNF changes from Semax translate to measurable cognitive gains in chemo survivors.\n\n## Safety and limits\n\nSemax has a history of use in certain countries for neurological conditions, but regulatory status and purity vary. Gabapentinoids carry standard side-effect profiles including dizziness and sedation. Anyone considering these approaches should consult their oncology team. Evidence does not support replacing standard care.","claims":[{"id":"c1","text":"No human trials test Semax in chemotherapy patients.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Sets baseline that all Semax-chemo links are indirect.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Semax increased BDNF protein 1.4-fold and trkB phosphorylation in rat hippocampus.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Core mechanistic finding for neural repair discussion.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"A 2024 meta-analysis found pregabalin did not significantly prevent CIPN pain or improve QoL vs placebo.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Grades the drug chain evidence directly.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Chemo brain involves memory and thinking changes reported during and after cancer treatment.","section":"What's breaking down","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Defines the cognitive degeneration layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://www.sciencedirect.com/science/article/abs/pii/S0006899306022955","title":"Semax regulates BDNF and trkB expression in the rat hippocampus","quote":"a single application of Semax (50 μg/kg body weight) results in a maximal 1.4-fold increase of BDNF protein levels","link_status":"http_403","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy","quote":"pregabalin did not significantly improve average pain ... or quality of life","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/diseases-conditions/chemo-brain/symptoms-causes/syc-20351060","title":"Chemo brain - Symptoms and causes","quote":"trouble with thinking and memory that can happen during and after cancer treatment","link_status":"http_403","quote_status":"unverified"}]},"rationale":"","tokens_in":12947,"tokens_out":2566,"cost":0.02259875,"prev_hash":"genesis","hash":"0e7c3b559f540a0ba8e995d579851f845fba19c8fc0fab530f0b1d0a6a47157a"}],"provenance":[{"ts":"2026-06-30T00:14:54.117Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Chemo\nSlug: semax-chemo\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[\"gabapentin-lyrica\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"gabapentin-lyrica\",\"name\":\"Gabapentin / pregabalin\",\"section_title\":\"Why Gabapentin / pregabalin matters for you\",\"steps\":[\"**Drug","response":"{\n  \"slug\": \"semax-chemo\",\n  \"title\": \"Semax for Chemo-Related Cognitive and Nerve Issues: Evidence Breakdown\",\n  \"body\": \"## What's breaking down\\n\\nChemotherapy often triggers two main layers of degeneration. One is chemo brain — trouble with memory, focus, and mental processing that can last months or years after treatment. The other is chemotherapy-induced peripheral neuropathy, with burning, numbness, or pain in hands and feet.\\n\\nThese happen because chemo agents damage neurons directly, raise inflammation in brain areas tied to cognition, and disrupt repair signals like BDNF. The result is breakdown that outpaces natural repair in many patients. Gabapentin and pregabalin mainly quiet pain signals without fixing the underlying nerve damage. Peptides like Semax are discussed for potential support of neural repair pathways instead.\\n\\n## Why Semax might help you\\n\\n1. What keeps failing: Chemo can lower BDNF levels and create cognitive fatigue plus neural stress similar to other neurotoxic loads.\\n2. What Semax is studied to do: Research shows it raises BDNF protein and mRNA in the rat hippocampus, supporting neuron connections and cognitive function without sedation.\\n3. Therefore for you: If your chemo brain or cognitive layer is active, Semax is examined because it targets repair at the BDNF/neural level rather than masking symptoms.\\n\\n## Why Gabapentin / pregabalin matters for you\\n\\n1. Drug: Gabapentin / pregabalin.\\n2. What it does: Masks neuropathic pain signals from chemo-induced nerve damage; does not repair nerves.\\n3. Therefore for you: It suppresses a signal. This can reduce daily pain load and improve sleep or function short-term, but it trades off against repair by not addressing the root degeneration — helpful for symptom control while other approaches target recovery.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semax targets the neural/cognitive repair layer. Gabapentin/pregabalin handles symptom suppression for neuropathy. They addre","tokens_in":12947,"tokens_out":2566,"cost":0,"prev":"genesis","hash":"6383f88c3fd8dff0d4632f7523a0f8bf935235be18103721498a170ab3b41c7f"},{"ts":"2026-07-17T02:41:52.044Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-chemo","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6383f88c3fd8dff0d4632f7523a0f8bf935235be18103721498a170ab3b41c7f","hash":"a28cd9a488e4e24f89647490861650cb133233d3039020b79889ddaf35b9fe07"}],"energy":{"passes":2,"tokens_in":12947,"tokens_out":2566,"tokens_total":15513,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"a28cd9a488e4e24f89647490861650cb133233d3039020b79889ddaf35b9fe07"},"posted_at":"2026-06-29T21:33:15.055Z","created_at":"2026-06-29T21:33:15.055Z","updated_at":"2026-07-17T02:41:52.044Z","machine":{"shape":"article.machine/v1","slug":"semax-chemo","kind":"article","read":{"human":"https://miscsubjects.com/a/semax-chemo","json":"https://miscsubjects.com/api/articles/semax-chemo","bundle":"https://miscsubjects.com/api/articles/semax-chemo/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/semax-chemo/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=semax-chemo","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-chemo\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-chemo\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/semax-chemo/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"semax-chemo\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/semax-chemo | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/semax-chemo","json":"/api/articles/semax-chemo","markdown":"/api/articles/semax-chemo/bundle?format=markdown","skill":"/api/articles/semax-chemo/skill","topology":"/api/articles/semax-chemo/topology","versions":"/api/articles/semax-chemo/revisions","invocations":"/api/articles/semax-chemo/invocations"},"editorial_review":null,"editorial_audit":{"slug":"semax-chemo","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"a2873dfc648247c58176fef05728baac8ccd99fcb7910e165f12479dcca4bae3","object":{"object_type":"article-object","identity":{"id":"article:semax-chemo","slug":"semax-chemo","title":"Semax for Chemo-Related Cognitive and Nerve Issues: Evidence Breakdown"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/semax-chemo","role":"explain","audience":"human"},"skill":{"route":"/api/articles/semax-chemo/skill","role":"direct behavior","audience":"model","content":"---\nname: semax-chemo\ndescription: Apply the Semax for Chemo-Related Cognitive and Nerve Issues: Evidence Breakdown article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Semax for Chemo-Related Cognitive and Nerve Issues: Evidence Breakdown\n\nThis Skill is the behavioral expression of [the canonical article](/a/semax-chemo). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/semax-chemo.\n- Read claims and relationships at /api/articles/semax-chemo/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Chemotherapy often triggers two main layers of degeneration. One is chemo brain — trouble with memory, focus, and mental processing that can last months or years after treatment. The other is chemotherapy-induced periph\n\n## Representations\n\n- Human: /a/semax-chemo\n- JSON: /api/articles/semax-chemo\n- Relationships: /api/articles/semax-chemo/topology\n- History: /api/articles/semax-chemo/revisions\n"},"json":{"route":"/api/articles/semax-chemo","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/semax-chemo/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","semax","chemo"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/semax-chemo/invocations?status=success","failure_events":"/api/articles/semax-chemo/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"semax-chemo","title":"Semax for Chemo-Related Cognitive and Nerve Issues: Evidence Breakdown","body":"## What's breaking down\n\nChemotherapy often triggers two main layers of degeneration. One is chemo brain — trouble with memory, focus, and mental processing that can last months or years after treatment. The other is chemotherapy-induced peripheral neuropathy, with burning, numbness, or pain in hands and feet.\n\nThese happen because chemo agents damage neurons directly, raise inflammation in brain areas tied to cognition, and disrupt repair signals like BDNF. The result is breakdown that outpaces natural repair in many patients. Gabapentin and pregabalin mainly quiet pain signals without fixing the underlying nerve damage. Peptides like Semax are discussed for potential support of neural repair pathways instead.\n\n## Why Semax might help you\n\n1. What keeps failing: Chemo can lower BDNF levels and create cognitive fatigue plus neural stress similar to other neurotoxic loads.\n2. What Semax is studied to do: Research shows it raises BDNF protein and mRNA in the rat hippocampus, supporting neuron connections and cognitive function without sedation.\n3. Therefore for you: If your chemo brain or cognitive layer is active, Semax is examined because it targets repair at the BDNF/neural level rather than masking symptoms.\n\n## Why Gabapentin / pregabalin matters for you\n\n1. Drug: Gabapentin / pregabalin.\n2. What it does: Masks neuropathic pain signals from chemo-induced nerve damage; does not repair nerves.\n3. Therefore for you: It suppresses a signal. This can reduce daily pain load and improve sleep or function short-term, but it trades off against repair by not addressing the root degeneration — helpful for symptom control while other approaches target recovery.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive repair layer. Gabapentin/pregabalin handles symptom suppression for neuropathy. They address different parts of the picture — one for potential rebuilding, one for load reduction — without overlap in mechanism.\n\n## What the evidence actually shows\n\nNo human trials test Semax specifically in chemotherapy patients. All direct data on Semax and BDNF come from rat studies. One study gave Semax to rats and measured a 1.4-fold rise in BDNF protein plus increased trkB activation in the hippocampus, linked to better avoidance learning. Another showed Semax boosted BDNF mRNA after brain ischemia in rats.\n\nChemo brain evidence is separate: human reports and imaging link cisplatin and other agents to cognitive changes via inflammation and mitochondrial shifts in brain cells. No Semax data connects to these models.\n\nFor gabapentinoids in CIPN, a 2024 meta-analysis of human trials found pregabalin did not significantly prevent average pain or improve quality of life versus placebo. Results in treatment settings were inconsistent across small studies. Overall evidence grade remains limited.\n\n## What scientists say\n\nResearchers note Semax modulates BDNF/trkB in preclinical models of cognitive function. Reviews on chemo brain emphasize the need for agents that support neurogenesis or reduce neuroinflammation, but no publications include Semax. CIPN guidelines list gabapentinoids as options with weak or conflicting support.\n\n## What people say on Reddit\n\nAnecdotal threads mention Semax in nootropic or post-chemo recovery contexts for focus, though specific chemo experiences are rare and unverified. Users often pair cognitive peptides with standard care but report variable subjective effects.\n\n## What people say on X\n\nPosts about Semax focus on general cognitive or recovery uses rather than chemo. Occasional mentions link peptides to chemo brain discussions without controlled data or consistent outcomes reported.\n\n## What we do not know\n\nHuman pharmacokinetics, dosing, or safety of Semax during or after chemotherapy remain unstudied. Long-term effects on cancer outcomes or interactions with chemo agents are unknown. No data exist on whether BDNF changes from Semax translate to measurable cognitive gains in chemo survivors.\n\n## Safety and limits\n\nSemax has a history of use in certain countries for neurological conditions, but regulatory status and purity vary. Gabapentinoids carry standard side-effect profiles including dizziness and sedation. Anyone considering these approaches should consult their oncology team. Evidence does not support replacing standard care.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/semax-chemo/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human trials test Semax in chemotherapy patients.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Sets baseline that all Semax-chemo links are indirect.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Semax increased BDNF protein 1.4-fold and trkB phosphorylation in rat hippocampus.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Core mechanistic finding for neural repair discussion.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"A 2024 meta-analysis found pregabalin did not significantly prevent CIPN pain or improve QoL vs placebo.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Grades the drug chain evidence directly.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Chemo brain involves memory and thinking changes reported during and after cancer treatment.","section":"What's breaking down","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Defines the cognitive degeneration layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://www.sciencedirect.com/science/article/abs/pii/S0006899306022955","title":"Semax regulates BDNF and trkB expression in the rat hippocampus","quote":"a single application of Semax (50 μg/kg body weight) results in a maximal 1.4-fold increase of BDNF protein levels","summary":"Rat study showing Semax effect on BDNF.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:14:53.456Z","link_status":"http_403","quote_status":"unverified","prev":"genesis","hash":"265efa4f20337f232deab8250a7b1bc00e9d63351e05b71df1d975d7a69d7d7a"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy","quote":"pregabalin did not significantly improve average pain ... or quality of life","summary":"Meta-analysis on gabapentinoids in CIPN.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:14:53.456Z","link_status":"ok","quote_status":"unverified","prev":"265efa4f20337f232deab8250a7b1bc00e9d63351e05b71df1d975d7a69d7d7a","hash":"aa8003576365864f2d121f10c946dd17398f84ceb443dde38e213594119e9a8a"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/diseases-conditions/chemo-brain/symptoms-causes/syc-20351060","title":"Chemo brain - Symptoms and causes","quote":"trouble with thinking and memory that can happen during and after cancer treatment","summary":"Clinical description of chemo brain.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:14:53.456Z","link_status":"http_403","quote_status":"unverified","prev":"aa8003576365864f2d121f10c946dd17398f84ceb443dde38e213594119e9a8a","hash":"ae164c4e39bfa06897c008a29e9a221e77c7209b211c98e3a809d0550af70e21"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:14:54.117Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Semax for Chemo-Related Cognitive and Nerve Issues: Evidence Breakdown","register":"source_ledger","body":"## What's breaking down\n\nChemotherapy often triggers two main layers of degeneration. One is chemo brain — trouble with memory, focus, and mental processing that can last months or years after treatment. The other is chemotherapy-induced peripheral neuropathy, with burning, numbness, or pain in hands and feet.\n\nThese happen because chemo agents damage neurons directly, raise inflammation in brain areas tied to cognition, and disrupt repair signals like BDNF. The result is breakdown that outpaces natural repair in many patients. Gabapentin and pregabalin mainly quiet pain signals without fixing the underlying nerve damage. Peptides like Semax are discussed for potential support of neural repair pathways instead.\n\n## Why Semax might help you\n\n1. What keeps failing: Chemo can lower BDNF levels and create cognitive fatigue plus neural stress similar to other neurotoxic loads.\n2. What Semax is studied to do: Research shows it raises BDNF protein and mRNA in the rat hippocampus, supporting neuron connections and cognitive function without sedation.\n3. Therefore for you: If your chemo brain or cognitive layer is active, Semax is examined because it targets repair at the BDNF/neural level rather than masking symptoms.\n\n## Why Gabapentin / pregabalin matters for you\n\n1. Drug: Gabapentin / pregabalin.\n2. What it does: Masks neuropathic pain signals from chemo-induced nerve damage; does not repair nerves.\n3. Therefore for you: It suppresses a signal. This can reduce daily pain load and improve sleep or function short-term, but it trades off against repair by not addressing the root degeneration — helpful for symptom control while other approaches target recovery.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive repair layer. Gabapentin/pregabalin handles symptom suppression for neuropathy. They address different parts of the picture — one for potential rebuilding, one for load reduction — without overlap in mechanism.\n\n## What the evidence actually shows\n\nNo human trials test Semax specifically in chemotherapy patients. All direct data on Semax and BDNF come from rat studies. One study gave Semax to rats and measured a 1.4-fold rise in BDNF protein plus increased trkB activation in the hippocampus, linked to better avoidance learning. Another showed Semax boosted BDNF mRNA after brain ischemia in rats.\n\nChemo brain evidence is separate: human reports and imaging link cisplatin and other agents to cognitive changes via inflammation and mitochondrial shifts in brain cells. No Semax data connects to these models.\n\nFor gabapentinoids in CIPN, a 2024 meta-analysis of human trials found pregabalin did not significantly prevent average pain or improve quality of life versus placebo. Results in treatment settings were inconsistent across small studies. Overall evidence grade remains limited.\n\n## What scientists say\n\nResearchers note Semax modulates BDNF/trkB in preclinical models of cognitive function. Reviews on chemo brain emphasize the need for agents that support neurogenesis or reduce neuroinflammation, but no publications include Semax. CIPN guidelines list gabapentinoids as options with weak or conflicting support.\n\n## What people say on Reddit\n\nAnecdotal threads mention Semax in nootropic or post-chemo recovery contexts for focus, though specific chemo experiences are rare and unverified. Users often pair cognitive peptides with standard care but report variable subjective effects.\n\n## What people say on X\n\nPosts about Semax focus on general cognitive or recovery uses rather than chemo. Occasional mentions link peptides to chemo brain discussions without controlled data or consistent outcomes reported.\n\n## What we do not know\n\nHuman pharmacokinetics, dosing, or safety of Semax during or after chemotherapy remain unstudied. Long-term effects on cancer outcomes or interactions with chemo agents are unknown. No data exist on whether BDNF changes from Semax translate to measurable cognitive gains in chemo survivors.\n\n## Safety and limits\n\nSemax has a history of use in certain countries for neurological conditions, but regulatory status and purity vary. Gabapentinoids carry standard side-effect profiles including dizziness and sedation. Anyone considering these approaches should consult their oncology team. Evidence does not support replacing standard care.","claims":[{"id":"c1","text":"No human trials test Semax in chemotherapy patients.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Sets baseline that all Semax-chemo links are indirect.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Semax increased BDNF protein 1.4-fold and trkB phosphorylation in rat hippocampus.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Core mechanistic finding for neural repair discussion.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"A 2024 meta-analysis found pregabalin did not significantly prevent CIPN pain or improve QoL vs placebo.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Grades the drug chain evidence directly.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Chemo brain involves memory and thinking changes reported during and after cancer treatment.","section":"What's breaking down","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Defines the cognitive degeneration layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:14:53.690Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://www.sciencedirect.com/science/article/abs/pii/S0006899306022955","title":"Semax regulates BDNF and trkB expression in the rat hippocampus","quote":"a single application of Semax (50 μg/kg body weight) results in a maximal 1.4-fold increase of BDNF protein levels","link_status":"http_403","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy","quote":"pregabalin did not significantly improve average pain ... or quality of life","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/diseases-conditions/chemo-brain/symptoms-causes/syc-20351060","title":"Chemo brain - Symptoms and causes","quote":"trouble with thinking and memory that can happen during and after cancer treatment","link_status":"http_403","quote_status":"unverified"}]},"rationale":"","tokens_in":12947,"tokens_out":2566,"cost":0.02259875,"prev_hash":"genesis","hash":"0e7c3b559f540a0ba8e995d579851f845fba19c8fc0fab530f0b1d0a6a47157a"}],"provenance":[{"ts":"2026-06-30T00:14:54.117Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Chemo\nSlug: semax-chemo\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[\"gabapentin-lyrica\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"gabapentin-lyrica\",\"name\":\"Gabapentin / pregabalin\",\"section_title\":\"Why Gabapentin / pregabalin matters for you\",\"steps\":[\"**Drug","response":"{\n  \"slug\": \"semax-chemo\",\n  \"title\": \"Semax for Chemo-Related Cognitive and Nerve Issues: Evidence Breakdown\",\n  \"body\": \"## What's breaking down\\n\\nChemotherapy often triggers two main layers of degeneration. One is chemo brain — trouble with memory, focus, and mental processing that can last months or years after treatment. The other is chemotherapy-induced peripheral neuropathy, with burning, numbness, or pain in hands and feet.\\n\\nThese happen because chemo agents damage neurons directly, raise inflammation in brain areas tied to cognition, and disrupt repair signals like BDNF. The result is breakdown that outpaces natural repair in many patients. Gabapentin and pregabalin mainly quiet pain signals without fixing the underlying nerve damage. Peptides like Semax are discussed for potential support of neural repair pathways instead.\\n\\n## Why Semax might help you\\n\\n1. What keeps failing: Chemo can lower BDNF levels and create cognitive fatigue plus neural stress similar to other neurotoxic loads.\\n2. What Semax is studied to do: Research shows it raises BDNF protein and mRNA in the rat hippocampus, supporting neuron connections and cognitive function without sedation.\\n3. Therefore for you: If your chemo brain or cognitive layer is active, Semax is examined because it targets repair at the BDNF/neural level rather than masking symptoms.\\n\\n## Why Gabapentin / pregabalin matters for you\\n\\n1. Drug: Gabapentin / pregabalin.\\n2. What it does: Masks neuropathic pain signals from chemo-induced nerve damage; does not repair nerves.\\n3. Therefore for you: It suppresses a signal. This can reduce daily pain load and improve sleep or function short-term, but it trades off against repair by not addressing the root degeneration — helpful for symptom control while other approaches target recovery.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semax targets the neural/cognitive repair layer. Gabapentin/pregabalin handles symptom suppression for neuropathy. They addre","tokens_in":12947,"tokens_out":2566,"cost":0,"prev":"genesis","hash":"6383f88c3fd8dff0d4632f7523a0f8bf935235be18103721498a170ab3b41c7f"},{"ts":"2026-07-17T02:41:52.044Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-chemo","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6383f88c3fd8dff0d4632f7523a0f8bf935235be18103721498a170ab3b41c7f","hash":"a28cd9a488e4e24f89647490861650cb133233d3039020b79889ddaf35b9fe07"}],"energy":{"passes":2,"tokens_in":12947,"tokens_out":2566,"tokens_total":15513,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"a28cd9a488e4e24f89647490861650cb133233d3039020b79889ddaf35b9fe07"},"posted_at":"2026-06-29T21:33:15.055Z","created_at":"2026-06-29T21:33:15.055Z","updated_at":"2026-07-17T02:41:52.044Z","machine":{"shape":"article.machine/v1","slug":"semax-chemo","kind":"article","read":{"human":"https://miscsubjects.com/a/semax-chemo","json":"https://miscsubjects.com/api/articles/semax-chemo","bundle":"https://miscsubjects.com/api/articles/semax-chemo/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/semax-chemo/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=semax-chemo","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-chemo\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-chemo\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/semax-chemo/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"semax-chemo\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/semax-chemo | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/semax-chemo","json":"/api/articles/semax-chemo","markdown":"/api/articles/semax-chemo/bundle?format=markdown","skill":"/api/articles/semax-chemo/skill","topology":"/api/articles/semax-chemo/topology","versions":"/api/articles/semax-chemo/revisions","invocations":"/api/articles/semax-chemo/invocations"},"editorial_review":null,"editorial_audit":{"slug":"semax-chemo","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"a2873dfc648247c58176fef05728baac8ccd99fcb7910e165f12479dcca4bae3"}}}